IMPACTS OF NEW EU MDR&IVDR REGULATIONS FOR TURKEY

Author(s)

Kahveci R1, Usakpinar P2
1Ankara Numune Training and Research Hospital, Ankara, Turkey, 23M Turkey, Istanbul, Turkey

OBJECTIVES: The New Regulations on Medical Devices, Regulation (EU) 2017/745 (MDR) and Regulation (EU) 2017/746 (IVDR), are recently under implementation period for Turkey. Turkish Medicines and Medical Device Agency (TMMDA) welcomes implementation to ensure better protection of public health and patient safety. This study analyses how the new regulations would impact medical devices sector in Turkey, both from industry and public perspectives.

METHODS: Regulations, literature regarding the regulatory changes, Turkish public and industry acts and relevant reactive publications were reviewed. The review complimented by interactions with different stakeholders to further explore the impact.

RESULTS: Regulations contain a series of important improvements to modernize the current system. Considering description changes for economic operators and classification rules for products both TMMDA and companies should monitor decisions and papers from EU commission. Translation for Turkish Language completed in cooperation with TMMDA and Trade Associations. New definitions for economic operators/Person responsible at medical device industry should assign their roles after TMMDA will clearly define for Turkish market. The conformity assessment process for medical devices will change,Notified Body (NB) designations should be able to complete at a time consistent with the EU for local NBs. Turkish Medical Device database will be expected to recognize and comply with European database as the registrations already will be transferred. Other changes for clinical trials, classification rules, post marketing surveillance should discuss within industry sessions and surveys for better understanding and timely adaptation.

CONCLUSIONS: Draft Turkish Regulation presented to the EU Commission should be continued to work in harmony with and cooperation with industry during the interpretation of it's effects and action plans. The adaptation of the regulation which is sufficiently comprehensive should be carried out within the framework of a plan within cooperation with the industry, taking into consideration the products on the market and the new products to come.

Conference/Value in Health Info

2018-11, ISPOR Europe 2018, Barcelona, Spain

Value in Health, Vol. 21, S3 (October 2018)

Code

PMD138

Topic

Health Policy & Regulatory

Topic Subcategory

Approval & Labeling, Pricing Policy & Schemes

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×